AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimilife-M2 Tablet PR

Prescription Icon
Prescription Required

Marketer

Lakshya Pharma Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimilife-M2 Tablet PR

Diabetam-Duo tablets are antidiabetic medications combining two active ingredients to manage type 2 diabetes in adults. This dual-action formulation helps regulate blood glucose. Diabetam-Duo should be ingested with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial; discontinuation without medical supervision can lead to elevated blood sugar, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is part of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle changes are essential for diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary foods, fruit juice) are vital to mitigate this risk. Alcohol consumption should be limited due to its potential to worsen hypoglycemia. Other possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. Diabetam-Duo is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Individuals with a history of heart disease should consult their physician before commencing treatment. Pregnant or breastfeeding women require medical consultation prior to use. Regular blood glucose monitoring and periodic blood tests (blood cell counts and liver function) are recommended.

Primary Ingredients of Glimilife-M2 Tablet PR

No text provided to rephrase.

Uses of Glimilife-M2 Tablet PR

Managing type 2 diabetes

Major Benefits of Glimilife-M2 Tablet PR:

Follow your doctor's instructions or consult the product label for usage guidelines. Take Glimilife-M2 Tablet PR with meals.

Common Side effects of Glimilife-M2 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimilife-M2 Tablet PR:

Follow your physician's instructions or consult the product labeling for usage guidance. Administer Glimilife-M2 Tablet PR with a meal.

How Glimilife-M2 Tablet PR works:

Glimilife-M2 Tablet PR combines glimepiride, a sulfonylurea, and metformin, a biguanide, to manage blood sugar. Glimepiride stimulates the pancreas to release more insulin, thus reducing blood glucose levels. Metformin acts by decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing the body's insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimilife-M2 Tablet PR with alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimilife-M2 Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Using Glimilife-M2 Tablet PR while breastfeeding poses a risk to the infant. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving may be impaired if your blood glucose is outside the normal range. Refrain from driving if you experience these symptoms.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Glimilife-M2 Tablet PR with care, potentially requiring dosage modification. Severe kidney disease contraindicates Glimilife-M2 Tablet PR use. Consult your physician. Regular monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimilife-M2 Tablet PR cautiously, potentially requiring dosage modification. Consult a physician for guidance. A low initial dose is generally prescribed for those with mild to moderate liver disease; the medication is unsuitable for patients with severe hepatic dysfunction.

What if you forget to take Glimilife-M2 Tablet PR :

Should you forget a dose of Glimilife-M2 Tablet PR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimilife-M2 Tablet PR

LabelValue
Developing Habits No.
Type of Treatment Diabetes Management

FAQs on Glimilife-M2 Tablet PR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's kept out of reach of children, pets, and others.
Glimilife-M2 Tablet PR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis, or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Glimilife-M2 Tablet PR and seek immediate medical attention.
Glimilife-M2 Tablet PR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This medication improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 DM.
Glimilife-M2 Tablet PR may cause common side effects including low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Glimilife-M2 Tablet PR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and balance problems (ataxia). To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Glimilife-M2 Tablet PR can indeed cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a readily available fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimilife-M2 Tablet PR and alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Glimilife-M2 Tablet PR
39
MRP 48
18% off